Kaya Ltd.

View in App
326.40 -0.15 ▼-0.1%

05 June 2023, 01:26:40 PM
Volume: 6,624

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.kaya.in
Market Cap 431.38 Cr.
Enterprise Value(EV) 516.23 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -89.15 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 48.55 Trailing Twelve Months Ending 2023-03
Book Value / Share -91.17 Trailing Twelve Months Ending 2023-03
Price to Book Value -3.61 Calculated using Price: 329.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.31 Cr. 13,064,091 Shares
FaceValue 10
About Kaya Ltd.
The company offers various skin care services and beauty treatments. Today, Kaya Clinics successfully offer best skin and hair care solutions that enhance the look and feel of your skin and hair beautifully. All of this takes place in our state-of-the-art and ambient clinics. Plus, the services that they offer are designed and supervised by a team of experts that include trained dermatologists and beauty therapists. Kaya's experts have also put forward in-depth research to develop products from 13 distinct skin care ranges. It is their concrete formulations that add to the efficiency of the products in order to meet customers’ customized beauty needs.

Kaya Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Kaya Ltd. Performance

View details >>
1 Day
-0.05%
1 Week
-4.49%
1 Month
-6.90%
3 Month
+15.93%
6 Month
-8.22%
1 Year
+4.15%
2 Year
-8.53%
5 Year
-61.37%
10 Year

Kaya Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 50.12 20.90 3.76 -11.41 -8.68 -7.57 -46.11 -55.98 -263.21
Return on Capital Employed (%) 22.58 16.56 5.43 -9.62 -5.06 -4.65 -7.24 -18.27 -53.94
Return on Assets (%) 9.99 8.99 2.24 -6.51 -4.87 -3.93 -14.21 -9.58 -18.64

Kaya Ltd. Balance Sheet

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 83 235 251 229 210 158 82 54 -2 -104
Non Curr. Liab. 121 15 18 5 2 10 142 131 166 224
Curr. Liab. 125 129 142 190 137 180 189 182 196 249
Minority Int. 0 2 2 1 1 0 1 1
Equity & Liab. 329 378 412 425 351 349 413 368 361 370
Non Curr. Assets 105 143 181 239 231 234 318 290 255 227
Curr. Assets 224 235 231 187 120 115 95 78 106 143
Misc. Exp. not W/O
Total Assets 329 378 412 425 351 349 413 368 361 370

Kaya Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 290 332 370 409 400 421 393 275 324 377
Other Income 81 15 12 11 10 4 9 15 12 5
Total Income 372 348 382 420 410 425 402 290 336 381
Total Expenditure -274 -296 -352 -425 -398 -406 -338 -248 -320 -401
PBIDT 97 52 30 -4 12 19 64 42 15 -20
Interest -4 -4 -4 -5 -7 -9 -22 -19 -21 -36
Depreciation -9 -12 -17 -20 -24 -29 -75 -60 -62 -60
Taxation -9 3 0 6 -21
Exceptional Items -37 -5
PAT 37 32 9 -27 -19 -14 -54 -37 -68 -116
Minority Interest 0 -1 -1 0 0 -1 -1 0
Share Associate -1 -1 -2
Other Related Items
Consolidated Net Profit 37 32 9 -29 -21 -16 -54 -38 -69 -116
Adjusted EPS 21 7 -22 -16 -12 -42 -29 -53 -89

Kaya Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 34 92 29 5 -8 -12 22 47 32 30
Cash Fr. Inv. -132 -11 -17 -6 -42 24 -28 -12 4 -35
Cash Fr. Finan. 115 -73 0 0 33 -7 5 -47 -31 12
Net Change 18 7 13 -2 -16 6 -1 -12 5 7
Cash & Cash Eqvt 25 14 28 28 14 20 19 7 12 20

Kaya Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 59.38 59.93 59.93 59.93 59.93 59.93 59.93 59.93 59.93
Public 40.62 40.07 40.07 40.07 40.07 40.07 40.07 40.07 40.07
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Kaya Ltd. Announcements

View details >>
Thu, 01 Jun 2023
Acquisition
Kaya Limited has informed the Exchange about Acquisition
Wed, 31 May 2023
Acquisition
Kaya Limited has informed the Exchange about Acquisition
Wed, 31 May 2023
Annual Secretarial Compliance Report
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2023

Kaya Ltd. Technical Scans

View details >>
Fri, 02 Jun 2023
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months
CCI Oversold Zone CCI Oversold Zone
Thu, 01 Jun 2023
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
S Making Lower Lows for 2 Days

Kaya Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 239,777.54 1,012.85 +1.3%
Divi's Laboratories Ltd. 93,340.08 3,465.00 -1.3%
Cipla Ltd. 77,917.34 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. 76,753.53 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. 71,422.15 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. 60,134.99 1,780.00 +0.1%
Mankind Pharma Ltd. 58,728.27 1,420.60 -3.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 28.30 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 51.54 3,465.00 -1.3%
Cipla Ltd. Consolidated 2023-03 27.85 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.03 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 87.03 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.23 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 43.99 1,420.60 -3.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.28 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7.36 3,465.00 -1.3%
Cipla Ltd. Consolidated 2023-03 3.33 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.30 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.52 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.69 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 5.65 1,420.60 -3.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,465.00 -1.3%
Cipla Ltd. Consolidated 2022-03 0.04 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 0.14 1,420.60 -3.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,465.00 -1.3%
Cipla Ltd. Consolidated 2022-03 13.10 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,420.60 -3.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,465.00 -1.3%
Cipla Ltd. Consolidated 2022-03 13.10 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 26.72 1,420.60 -3.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,465.00 -1.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 7,781.56 1,420.60 -3.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,012.85 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,465.00 -1.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 971.00 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,617.25 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,965.00 0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,780.00 +0.1%
Mankind Pharma Ltd. Standalone 2022-03 1,452.96 1,420.60 -3.1%

Kaya Ltd. FAQ's

What is Kaya share price?
Can I buy Kaya shares now?
What is the Market Cap of Kaya?
What is the 52 Week High and Low of Kaya?
What is the trend of Kaya share price?